31 CD44-Gal9 Interaction between IDH1-mutant Grade 4 Astrocytoma and Microglia Promotes Invasion and Proliferation of Tumor Cells

Clicks: 14
ID: 326706
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #258 of 287 articles by views in journal of neuro-oncology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 287 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Introduction IDH1-mutant grade 4 astrocytomas exhibit pronounced interactions with the tumor microenvironment that critically influence tumor progression. Tumor-associated microglia/macrophages (TAMs) are key mediators of these interactions, yet the molecular mechanisms governing tumor-TAM crosstalk remain incompletely understood. Here, we investigated the role of CD44-Galectin-9 (Gal9) signaling in patient-derived IDH1-mutant astrocytoma models. Method scRNA-seq was performed on paired primary and recurrent high-grade astrocytomas to assess CD44 and Gal9 expression. CD44 was suppressed in tumor cells using shRNA-mediated knockdown, with or without exogenous Gal9. Conditioned media from control or CD44 knockdown tumor cells was applied to induced pluripotent stem cell-derived microglia (iMGs) to evaluate phagocytic activity. Tumor behavior was further assessed in 3D cerebral organoid co-culture models. Immunofluorescence analyses were used to examine spatial expression patterns of CD44 and Gal9. Results scRNA-seq analysis revealed marked overexpression of CD44 in tumor cells, while Gal9 expression was predominantly associated with TAMs. CD44 knockdown significantly reduced tumor cell proliferation and invasion in vitro. Exogenous Gal9 enhanced proliferative and invasive behavior in control tumor cells, whereas CD44-deficient cells were unresponsive, indicating a CD44-dependent pro-tumorigenic effect of Gal9. Conditioned media from CD44 knockdown tumor cells increased microglial phagocytic activity, suggesting altered tumor-mediated immune modulation. In 3D cerebral organoid co-cultures, CD44 knockdown tumor cells exhibited reduced invasion and proliferation. Immunofluorescence revealed peritumoral enrichment of Gal9 expression in iMGs, which was diminished in CD44 knockdown samples, with CD44 and Gal9 expression showing a strong positive correlation across models. Conclusions Together, these data identify CD44-Gal9 signaling as a clinically relevant axis promoting tumor invasiveness and immune evasion in IDH1-mutant astrocytomas. Therapeutic inhibition of this interaction may represent a promising strategy to simultaneously attenuate tumor aggressiveness and reprogram the tumor microenvironment.
Reference Key
openalex_W7204448913 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Nathalie Grosse, Felix Sahm, Christel Herold-Mende, Şevin Turcan
Are you one of these authors? Claim your profile
Journal journal of neuro-oncology
Year 2026
DOI
10.1093/neuonc/noag172.014
URL
https://academic.oup.com/neuro-oncology/article-pdf/28/Supplement_1/noag172.014/70805839/noag172.014.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.